Profile
Armin Reininger is Head-Global Medical & Scientific Affairs at Swedish Orphan Biovitrum AB. In the past he held the position of Head-Global Medical Affairs Hematology at Baxalta, Inc. and Professor at Ludwig-Maximilians-Universität München. Dr. Reininger received a doctorate from Ludwig-Maximilians-Universität München.
Armin Reininger active positions
| Companies | Position | Start |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 06/01/2017 |
Former positions of Armin Reininger
| Companies | Position | End |
|---|---|---|
| BAXALTA INC | Chief Tech/Sci/R&D Officer | - |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Armin Reininger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
- Stock Market
- Insiders
- Armin Reininger
















